NYSE

TransUnion (TRU)

609 Thanks from members

TransUnion (TRU) exhibits strong Q2 earnings outperformance with 15% revenue growth and an upgraded 2026 outlook, though shares faced unexpected post-earnings volatility, profit-taking, and valuation resets alongside ongoing balance sheet debt concerns.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →